A review of patient data suggests that combining chemotherapy with traditional Chinese medicine (TCM) can lead to better outcomes for people with advanced non-small cell lung cancer. The study looked at how these treatments affected overall survival and the amount of time patients lived without their cancer progressing.
The results showed that patients receiving both therapies had significantly better progression-free survival compared to those receiving chemotherapy alone. However, while the combination therapy improved overall survival initially, this specific benefit was found to diminish over time. The study also noted that the benefits were most consistent in groups following a fixed TCM regimen rather than personalized plans.
Because this research includes both randomized trials and observational studies, it shows an association rather than a direct cause. Additionally, some statistical limitations were noted regarding how survival was measured over long periods. Patients should talk to their doctors to see if these combined therapies are appropriate for their specific treatment plan.
